FDA limits J&J COVID-19 vaccine due to rare blood clot risk
2:56pm PDT - May 5th, 2022 johnson and johnson vaccine - ABC NewsThe Food and Drug Administration has limited its authorization of the Johnson & Johnson COVID-19 vaccine due to the rare risk of blood clots.